• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低铝水和去铁胺对透析性脑病结局的影响。

The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.

作者信息

Milne F J, Sharf B, Bell P, Meyers A M

出版信息

Clin Nephrol. 1983 Oct;20(4):202-7.

PMID:6641027
Abstract

Five patients with dialysis encephalopathy were transferred to deionized water; all died after a variable period, 4 of progressive dementia. Six other patients with encephalopathy were started either on deionized or reverse osmosis water as well as desferrioxamine on dialysis. Serial EEG's were performed in this group. In 2 patients the EEG's showed rapid and sustained improvement after the institution of desferrioxamine, whereas there had been no EEG change after 15 and 32 months of reverse osmosis water. In 2 patients there was similar clinical and EEG improvement, related to water change and the institution of desferrioxamine. Two patients died of progressive dementia in spite of both water change and desferrioxamine. Thus, while not a panacea, desferrioxamine has a definitive therapeutic effect on the clinical and EEG manifestations of dialysis encephalopathy, when used in conjunction with deionized or reverse osmosis water.

摘要

五名患有透析性脑病的患者改用去离子水;所有患者在一段不同的时间后均死亡,其中4例死于进行性痴呆。另外六名患有脑病的患者在透析时开始使用去离子水或反渗透水以及去铁胺。对该组患者进行了系列脑电图检查。在2例患者中,使用去铁胺后脑电图显示迅速且持续改善,而使用反渗透水15个月和32个月后脑电图无变化。在2例患者中,临床和脑电图有类似改善,与水的更换及使用去铁胺有关。尽管更换了水并使用了去铁胺,仍有2例患者死于进行性痴呆。因此,去铁胺虽不是万灵药,但与去离子水或反渗透水联合使用时,对透析性脑病的临床和脑电图表现具有确切的治疗作用。

相似文献

1
The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.低铝水和去铁胺对透析性脑病结局的影响。
Clin Nephrol. 1983 Oct;20(4):202-7.
2
Role of desferrioxamine in the treatment of dialysis encephalopathy.
Kidney Int Suppl. 1986 Feb;18:S104-7.
3
Progressive dialysis encephalopathy from dialysate aluminum.
Arch Intern Med. 1978 Sep;138(9):1375-7.
4
Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum-free fluids.大量使用无铝透析液透析的患者群体中血清铝浓度与脑病体征之间的相关性。
Clin Nephrol. 1988 Jun;29(6):294-8.
5
[Successful treatment of progressive dialysis encephalopathy. Case report].[成功治疗进行性透析性脑病。病例报告]
Z Urol Nephrol. 1985 Jul;78(7):387-93.
6
[Water purification in dialysis treatment. Aluminum and encephalopathy].[透析治疗中的水净化。铝与脑病]
Lakartidningen. 1980 Jun 25;77(26-27):2425-7.
7
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.慢性肾衰竭中的脑病对去铁胺治疗有反应。铝神经毒性的另一种表现。
Arch Intern Med. 1986 Oct;146(10):2063-4.
8
Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
Neth J Med. 1985;28(1):6-11.
9
The EEG in progressive dialysis encephalopathy. The EEG and clinical indices of PDE in cases treated with desferrioxamine. (Part. II).进行性透析性脑病的脑电图。用去铁胺治疗的进行性透析性脑病病例的脑电图及临床指标。(第二部分)
Ital J Neurol Sci. 1984 Dec;5(4):375-80. doi: 10.1007/BF02042619.
10
Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.去铁胺治疗后铝透析脑病的逆转
Lancet. 1981 Nov 14;2(8255):1116. doi: 10.1016/s0140-6736(81)91324-6.

引用本文的文献

1
Clinical aspects of dialysis encephalopathy.透析性脑病的临床方面
Environ Geochem Health. 1990 Mar;12(1-2):87-8. doi: 10.1007/BF01734055.
2
Recent developments in aluminum toxicology.铝毒理学的最新进展。
Med Toxicol Adverse Drug Exp. 1989 Jan-Feb;4(1):1-16. doi: 10.1007/BF03259899.
3
Aluminum effect on the activity of superoxide dismutase and of other antioxygenic enzymes in vitro.铝对超氧化物歧化酶及其他抗氧化酶体外活性的影响。
Biol Trace Elem Res. 1991 Oct;31(1):79-96. doi: 10.1007/BF02990362.